1 / 21

Ali …. 65 years old C/O exercise intolerance for 2 years

Ali …. 65 years old C/O exercise intolerance for 2 years. History of occasional wheeze “ slight cough for a while” “5 may be 10 years” Morning sputum most of the time Smoked on and off for 40 years / 1.5 packs No clubbing Wheeze and hyperinflation. FEV1 / FVC < 70 %

toril
Télécharger la présentation

Ali …. 65 years old C/O exercise intolerance for 2 years

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ali …. 65 years old C/O exercise intolerance for 2 years

  2. History of occasional wheeze • “slight cough for a while” “5 may be 10 years” • Morning sputum most of the time • Smoked on and off for 40 years / 1.5 packs • No clubbing • Wheeze and hyperinflation

  3. FEV1 / FVC < 70 % • Diffusing capacity(DLco) • Kco reduced

  4. Saleh 55 years smoked 60 since age 16Barrel-shapedLiver 6th spaceCough, expectoration, SOB 2 yearsFEV1 44% FEF 19% RV%TLC 200% FEV1 / FVC 60%Ventolin neb. 5mg----FEV1 INCREASED 140 ml (10%)

  5. KCO 98%Allergic rhinitis and hypret. TurbinatesSOB triggered strongly by dust and irritants • A trial of Symbicort for 3 weeks • FEV1 and FEF50 rose to 80% • FEV1 relapsed to 64% but recovered

  6. Airways obstruction in patients with long-term asthma consistent with ‘irreversible asthma’ Backman et al. Chest 1996 • A series of 8 patients aged 41-58 • Post salb. FEV1 26% to 57% • All on oral corticosteroids • Mean duration of asthma 39 years • “ end stage “ irreversible asthma • KCO 81% to 107%

  7. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma • 92 subjects 18-64 years • BA for 16 years all reversible • FU 10 years • 23% became irreversible • Yet both groups maintained normal KCO and TLCO Eur Respir J 1999

  8. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction • Hudon et al. 1997 • 2 groups : reversible V irreversible • FEV1 : 89% V 48% • Duration : 17 years V 31 years • Thicker bronchial wall on HRCT scan • Lung compliance and KCO the same

  9. Airways inflammation in asthma with incomplete reversibility of airflow obstruction • 15 IRAO FEV1 54% • 23 CRAO FEV1 84% • Non smoker • Sputum induction • FEV1 inversely correlated with % neutrophils not eosinophils Resp Med 2003

  10. Airway remodelling is correlated with obstruction in childrenAllergy 2008 • 5-14 years old • Persistent obstruction in spite of ICS and systemic corticost. increased ASM increased blood vessels

  11. Clinical,physiological and radiological features of asthma with incomplete reversibility compared with COPD • Boulet et al. 1998 • AIRAO 14 V COPD 13 cases • Atopy 13 V 1 • FEV1 49% V 39% • Revers. 22% V 18% • DLCO 89% V 62% • Mod. To severe emphysema 0 V 10/13

  12. Asthma is not a common cause of severe chronic respiratory failure in non-smokers : ALTOT STUDY • All cases of domiciliary LTOT in an Italian district • 114 (all smokers) had COPD • 70 (all smokers) had other conditions • None had a history of BA

  13. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma… • Allergy Humbert et al 2003 • ICS/LABA • Reduced severe exacerbations by half

  14. ERS/Gold 1. Airways obsturction Smokers NS Ex-S White men White women 14.2% 13.6% 3.3% 3.1% 6.9% 6.8%

  15. C O U G H Smokers NS Ex-S White men White women 24% 20% 4% 5% 4.7% 6.5%

  16. Practical Plan • Bullae or chronic respiratory failure—COPD • Below 50 • History of atopy or strong triggering • NORMAL KCO

  17. ICS trial • Symbicort • Seretide MDI • 3 weeks

  18. A study at KKUH on smokers bearing the diagnosis of BA or COPD • 40 diagnosed BA Only 1 re-diagnosed COPD Confirmed by irreversibility low KCO histology

  19. 40 diagnosed COPD 12 full reversibility + normal KCO 5 remained irreversible normal KCO HISTOLOGY

More Related